EGFR and lung carcinoma: Each study used EGFR-mutated lung cancer cell lines to identify candidate essential molecule(s)/pathway(s) for DTC induction by establishing DTCs via short-term exposure to EGFR TKIs (Figure 2A) or by using shRNA-, siRNA-, or CRISPR/Cas9-mediated screening (Figure 2B).